首页 正文

AXL Inhibitors in Oncology Clinical Trials: A Review

{{output}}
The AXL receptor tyrosine kinase is a transmembrane protein commonly overexpressed in both solid and hematologic malignancies. AXL plays a role in malignant cell growth, survival, proliferation, and adaptive immunity. As such, AXL overexpression is correlated ... ...